| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Systematic review: the costs of ulcerative colitis in Western countries | Alimentary Pharmacology and Therapeutics | 2010 | 237 |
| 2 | <p>The burden of critical limb ischemia: a review of recent literature</p> | Vascular Health and Risk Management | 2019 | 205 |
| 3 | Societal cost of rheumatoid arthritis patients in the US | Current Medical Research and Opinion | 2010 | 197 |
| 4 | Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis | Rheumatology | 2010 | 190 |
| 5 | The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study | Health and Quality of Life Outcomes | 2006 | 174 |
| 6 | Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis | British Journal of Dermatology | 2008 | 150 |
| 7 | Impact of adalimumab treatment on patient‐reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis | Journal of Dermatological Treatment | 2007 | 91 |
| 8 | Quantifying the economic burden of productivity loss in rheumatoid arthritis | Rheumatology | 2011 | 91 |
| 9 | Adalimumab treatment is associated with improvement in health‐related quality of life in psoriasis: Patient‐reported outcomes from a Phase II randomized controlled trial | Journal of Dermatological Treatment | 2007 | 75 |
| 10 | Economic evaluation of systemic therapies for moderate to severe psoriasis | British Journal of Dermatology | 2009 | 74 |
| 11 | Cost‐effectiveness of biologic response modifiers compared to disease‐modifying antirheumatic drugs for rheumatoid arthritis: A systematic review | Arthritis Care and Research | 2011 | 74 |
| 12 | Dosage adjustment during long-term adalimumab treatment for Crohnʼs disease: Clinical efficacy and pharmacoeconomics | Inflammatory Bowel Diseases | 2011 | 73 |
| 13 | Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis | Arthritis Research and Therapy | 2009 | 70 |
| 14 | Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: Work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study | Arthritis Care and Research | 2010 | 56 |
| 15 | Health System Quality Improvement | Journal of Nursing Care Quality | 2016 | 51 |
| 16 | Retrospective claims data analysis of dosage adjustment patterns of TNF antagonists among patients with rheumatoid arthritis | Current Medical Research and Opinion | 2008 | 50 |
| 17 | The Evolution of Work from Home | Journal of Economic Perspectives | 2023 | 49 |
| 18 | Resolving Bipolar Electrogram Voltages During Atrial Fibrillation Using Omnipolar Mapping | Circulation: Arrhythmia and Electrophysiology | 2017 | 43 |
| 19 | Reducing Uncertainty in Value-Based Pricing Using Evidence Development Agreements | Applied Health Economics and Health Policy | 2010 | 42 |
| 20 | Angina and associated healthcare costs following percutaneous coronary intervention: A real‐world analysis from a multi‐payer database | Catheterization and Cardiovascular Interventions | 2016 | 41 |
| 21 | Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study | Health and Quality of Life Outcomes | 2008 | 40 |
| 22 | Comparison of FACT- and EQ-5D–Based Utility Scores in Cancer | Value in Health | 2012 | 40 |
| 23 | Transcatheter Valve Therapy Registry Is A Model For Medical Device Innovation And Surveillance | Health Affairs | 2015 | 39 |
| 24 | Chronic kidney disease in gout in a managed care setting | BMC Nephrology | 2011 | 38 |
| 25 | Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis | Health and Quality of Life Outcomes | 2011 | 34 |
| 26 | Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States | Journal of Dermatological Treatment | 2011 | 32 |
| 27 | The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysis | BMJ Open | 2017 | 32 |
| 28 | Health State Utilities Associated with Glucose Monitoring Devices | Value in Health | 2017 | 32 |
| 29 | Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants | Italian Journal of Pediatrics | 2009 | 31 |
| 30 | Law and Culture: A Theory of Comparative Variation in Bona Fide Purchase Rules | Oxford Journal of Legal Studies | 2015 | 29 |
| 31 | Identifying cost-effective screening algorithms for active hepatitis C virus infections in a high prevalence setting | Journal of Medical Economics | 2018 | 29 |
| 32 | Cost effectiveness of palivizumab in Spain: an analysis using observational data | European Journal of Health Economics | 2010 | 28 |
| 33 | Targeting malnutrition: Nutrition programs yield cost savings for hospitalized patients | Clinical Nutrition | 2020 | 28 |
| 34 | Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis | Rheumatology | 2007 | 25 |
| 35 | Impact of a Nutrition-Focused Quality Improvement Intervention on Hospital Length of Stay | Journal of Nursing Care Quality | 2019 | 25 |
| 36 | Qualitative assessment of the content validity of the Dermatology Life Quality Index in patients with moderate to severe psoriasis | Journal of Dermatological Treatment | 2013 | 24 |
| 37 | Interstate Variation in the Burden of Fragility Fractures | Journal of Bone and Mineral Research | 2009 | 22 |
| 38 | Development and initial psychometric evaluation of the hepatitis C virus-patient-reported outcomes (HCV-PRO) instrument | Quality of Life Research | 2014 | 22 |
| 39 | HCV core antigen comes of age: a new opportunity for the diagnosis of hepatitis C virus infection | Clinical Chemistry and Laboratory Medicine | 2018 | 22 |
| 40 | Cost-Effectiveness of a Specialized Oral Nutritional Supplementation for Malnourished Older Adult Patients in Spain | Nutrients | 2018 | 21 |
| 41 | Changes in Utilization and Costs for Patients with Rheumatoid Arthritis, 1997 to 2006 | Pharmacoeconomics | 2012 | 20 |
| 42 | How a Malnutrition Quality Improvement Initiative Furthers Malnutrition Measurement and Care: Results From a Hospital Learning Collaborative | Journal of Parenteral and Enteral Nutrition | 2021 | 20 |
| 43 | Impact of the medicare modernization act of 2003 on utilization and spending for medicare part B–covered biologics in rheumatoid arthritis | Arthritis Care and Research | 2010 | 18 |
| 44 | Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial | Quality of Life Research | 2014 | 18 |
| 45 | Effects of parental and household smoking on the risk of respiratory syncytial virus (RSV) hospitalisation in late-preterm infants and the potential impact of RSV prophylaxis | Journal of Maternal-Fetal and Neonatal Medicine | 2013 | 17 |
| 46 | US Hospital Payment Adjustments For Innovative Technology Lag Behind Those In Germany, France, And Japan | Health Affairs | 2015 | 17 |
| 47 | Economics of Cancer Biomarkers | Personalized Medicine | 2012 | 16 |
| 48 | Workplace impacts of anti-TNF therapies in rheumatoid arthritis: review of the literature | Expert Opinion on Pharmacotherapy | 2009 | 15 |
| 49 | Cost Effectiveness of Paricalcitol versus a Non-Selective Vitamin D Receptor Activator for Secondary Hyperparathyroidism in the UK | Clinical Drug Investigation | 2010 | 15 |
| 50 | Cost‐effectiveness analysis of palivizumab as respiratory syncytial virus prophylaxis in preterm infants in Sweden | Acta Paediatrica, International Journal of Paediatrics | 2011 | 15 |
